Charlie’s Holdings Reports First Quarter 2024 Results
Increasing Awareness and Market Share of SPREE BAR™ - with Proprietary Metatine™ Inside - Throughout 2024COSTA MESA, CA / ACCESSWIRE...
Month: May 2024
Coastal Vision Medical Group Pioneers SMILE Pro With the VisuMax(R) 800
First Practice West of Dallas to Offer Revolutionary Vision Correction TechnologyORANGE, CA / ACCESSWIRE / May 20, 2024 / Coastal...
Fast Pace Health Recognizes Mental Health Awareness Month and Expands Access to Care
FRANKLIN, TN / ACCESSWIRE / May 20, 2024 / At the core of Fast Pace Health's mission lies a profound...
Emergency Care Partners Recognized as One of the Best Places to Work in Healthcare 2024
CHICAGO, IL / ACCESSWIRE / May 20, 2024 / Emergency Care Partners (ECP) has been selected by Modern Healthcare as...
Akanda Announces Closing of Subsequent Registered Direct Offering
London, United Kingdom--(Newsfile Corp. - May 20, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical...
American Society for Gastroenterology and Endoscopy Launches Artificial Intelligence Institute at Digestive Disease Week
The Institute’s mission is to integrate AI into GI care to improve patient outcomes and drive innovation in gastroenterology.WASHINGTON--(BUSINESS WIRE)--The...
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
The SON-1010 studies have together enrolled 61 subjects, to date, as dose escalation continues in SB101 and SB221 at higher...
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company’s AI Program Data Show That Applying AI...
Masimo Receives Sustainability Seal of Approval from Practice Greenhealth
Masimo Becomes First Pulse Oximetry Manufacturer to be Recognized with Coveted “Greenhealth Approved” SealIRVINE, Calif. & RESTON, Va.--(BUSINESS WIRE)--Masimo (NASDAQ:...
Study in the Journal of the American Heart Association Links Hello Heart Usage to Significant Reductions in Blood Pressure, Cholesterol, and Weight
MENLO PARK, Calif.--(BUSINESS WIRE)--A new peer-reviewed study in the Journal of the American Heart Association found that Hello Heart’s digital...
Unite Us Introduces Real-Time Medicaid Member Eligibility Verification to Increase Enrollment and Streamline Reimbursement for Social Care
New integration reduces administrative burdens by integrating with Medicaid systems to swiftly verify eligibility, enroll members in essential social care...
CBIH Engages Prestigious Law Firm for its First Patent Applications
Houston, Texas--(Newsfile Corp. - May 20, 2024) - Cannabis Bioscience International Holdings(OTC Pink: CBIH), utilizing robust methodologies to safeguard its...
VivaWell and Shen.AI Announce Strategic Partnership to Transform Health Monitoring in Mexico and Argentina
MEXICO CITY, MEXICO / ACCESSWIRE / May 20, 2024 / In a significant move to revolutionize digital health and wellness...
Hypha Labs Announces New Patent Filing
New Patent Portfolio Unveiled Revolutionizing Psilocybin ProcessingLAS VEGAS, NV / ACCESSWIRE / May 20, 2024 / Hypha Labs, Inc. (OTC...
CNS Pharmaceuticals to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase
Live webcast fireside chat on Tuesday, May 21st at 1:40 PM ETHOUSTON, TX / ACCESSWIRE / May 20, 2024 /...
Nava Health To Attend 4th Annual Benchmark Virtual Healthcare Conference
COLUMBIA, MD / ACCESSWIRE / May 20, 2024 / Nava Health MD, Inc. ("Nava Health" or "Nava"), a leader in...
Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NV-387, A Broad-Spectrum Antiviral with Strong Activity Against RSV, Influenza A, Coronaviruses, Others SHELTON, CT / ACCESSWIRE / May 20,...
GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
Compared to controls, mice treated with GRI-0621 showed improved fibrosis and immunopathology; Inhibition of type 1 invariant Natural Killer T...
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader...
Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer
Waiver confirms that paediatric studies of certepetide in pancreatic cancer are not needed Significant clinical trial burden and costs avoided...